Paterson David L
Antibiotic Management Program and Transplant Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S90-5. doi: 10.1086/499407.
Managing serious infections is a balance between providing timely and appropriate broad-spectrum empirical therapy for individual patients, which has been consistently shown to improve outcomes, and reducing unnecessary use of antimicrobial agents, which may contribute to the development of antimicrobial resistance. To control the spread of antimicrobial resistance, hospitals commonly implement programs designed to optimize antimicrobial use, supported by infection-control measures. Hospital-based antimicrobial management programs--also called "antimicrobial stewardship programs"--are primarily based on education coupled with a "front-end" approach (i.e., restricting the availability of selected antimicrobial agents) or a "back-end" approach (i.e., reviewing broad-spectrum empirical therapy and then streamlining or discontinuing therapy, as indicated, on the basis of culture and susceptibility testing results and clinical response). Institutional efforts to optimize antimicrobial use should concentrate on patient outcomes, should have multidisciplinary support, and should use a combination of interventions customized to the needs, resources, and information technology infrastructure of the health care institution.
管理严重感染需要在为个体患者提供及时且恰当的广谱经验性治疗(这已被持续证明可改善治疗结果)与减少抗菌药物的不必要使用(这可能会促进抗菌药物耐药性的发展)之间取得平衡。为控制抗菌药物耐药性的传播,医院通常会实施旨在优化抗菌药物使用的项目,并辅以感染控制措施。基于医院的抗菌管理项目——也称为“抗菌药物管理项目”——主要基于教育,并结合“前端”方法(即限制某些抗菌药物的可得性)或“后端”方法(即审查广谱经验性治疗,然后根据培养和药敏试验结果及临床反应,酌情简化或停止治疗)。医疗机构优化抗菌药物使用的努力应专注于患者的治疗结果,应获得多学科支持,并应结合根据医疗机构的需求、资源和信息技术基础设施量身定制的多种干预措施。